Path ID: DB00194_MESH_D016849_1

db00194-mesh-d016849-1

Concepts

Identifier Name Type
MESH:D014740 vidarabine Drug
MESH:D001084 Vidarabine Phosphate ChemicalSubstance
UniProt:P04293 DNA polymerase catalytic subunit Protein
GO:0039686 bidirectional double-stranded viral DNA replication BiologicalProcess
GO:0090503 RNA phosphodiester bond hydrolysis, exonucleolytic BiologicalProcess
GO:0043631 RNA polyadenylation BiologicalProcess
taxonomy:10299 Human alphaherpesvirus 1 strain 17 OrganismTaxon
MESH:D016849 Keratitis, Herpetic Disease

Relationships

NOTE: predicates are annotated in Biolink Model (v1.3.0)

Subject Predicate Object
Vidarabine HAS METABOLITE Vidarabine Phosphate
Vidarabine Phosphate DECREASES ACTIVITY OF Dna Polymerase Catalytic Subunit
Dna Polymerase Catalytic Subunit POSITIVELY REGULATES Bidirectional Double-Stranded Viral Dna Replication
Dna Polymerase Catalytic Subunit POSITIVELY REGULATES Rna Phosphodiester Bond Hydrolysis, Exonucleolytic
Dna Polymerase Catalytic Subunit POSITIVELY REGULATES Rna Polyadenylation
Rna Polyadenylation IN TAXON Human Alphaherpesvirus 1 Strain 17
Bidirectional Double-Stranded Viral Dna Replication IN TAXON Human Alphaherpesvirus 1 Strain 17
Rna Phosphodiester Bond Hydrolysis, Exonucleolytic IN TAXON Human Alphaherpesvirus 1 Strain 17
Human Alphaherpesvirus 1 Strain 17 CAUSES Keratitis, Herpetic

Comment: This disease is also known as Herpes simplex keratitis as per DrugCentral. The drug needs to be converted to Vidarabine Phosphate first (monophosphate –> diphosphate –> triphosphate) to become active and exert its role as inhibitor (https://pubchem.ncbi.nlm.nih.gov/compound/21704#section=Mechanism-of-Action).

Reference: